A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies

T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have greatly expanded donor availability and are increasingly utilized. Haplo were originally performed using truly nonmyeloablative conditioning and a bone marrow graft. We have also developed myeloablative con...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Adv Hematol
Auteurs principaux: Solh, Melhem M., Hinojosa, Gabriel, Laporte, Justin, Solomon, Scott R., Morris, Lawrence E., Zhang, Xu, Holland, H. Kent, Bashey, Asad
Format: Artigo
Langue:Inglês
Publié: Hindawi 2021
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8009703/
https://ncbi.nlm.nih.gov/pubmed/33859695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/8868142
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires